Monitoring antiretroviral therapy in low and middle-income countries: current status and future considerations

Affiliations

¹ HIV/Infectious Diseases Unit, "Villa Maraini" Foundation, Rome/Infectious Diseases Unit, "San Camillo de Lellis" Hospital, Rieti, Italy.
² Department of Paediatrics and Child Health, School of Medicine, College of Health Sciences, Makerere University/Research Department, Joint Clinical Research Centre, Kampala, Uganda.
³ Department of Microbiology & Immunology, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand.

Editorial

Mauro Zaccarelli et al. AIDS. 2022.

. 2022 Nov 15;36(14):2071-2073.

doi: 10.1097/QAD.0000000000003381.

¹ HIV/Infectious Diseases Unit, "Villa Maraini" Foundation, Rome/Infectious Diseases Unit, "San Camillo de Lellis" Hospital, Rieti, Italy.
² Department of Paediatrics and Child Health, School of Medicine, College of Health Sciences, Makerere University/Research Department, Joint Clinical Research Centre, Kampala, Uganda.
³ Department of Microbiology & Immunology, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand.

No abstract available

Comment on

A randomized study of intensified antiretroviral treatment monitoring versus standard-of-care for prevention of drug resistance and antiretroviral treatment switch.
Hermans LE, Ter Heine R, Schuurman R, Tempelman HA, Burger DM, Vervoort SCJM, Deville WLJM, De Jong D, Venter WDF, Nijhuis M, Wensing AMJ. Hermans LE, et al. AIDS. 2022 Nov 15;36(14):1959-1968. doi: 10.1097/QAD.0000000000003349. Epub 2022 Oct 4. AIDS. 2022. PMID: 35950949 Free PMC article. Clinical Trial.

1. Hermans LE, Ter Heine R, Schuurman R, Tempelman HA, Burger DM, Vervoort S, et al. A randomised study of intensified ART monitoring versus standard-of-care for prevention of drug resistance and ART switch . AIDS 2022; 36:1959–1968.
1. South African National Department of Health. 2019 ART clinical guidelines for the management of HIV in adults, pregnancy, adolescents, children, infants, and neonates. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2955519/ .
1. World Health Organization. Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring [Internet]. 2021. http://apps.who.int/bookorders .
1. Pasquet A, Messou E, Gabillard D, Minga A, Depoulosky A, Deuffic-Burban S, et al. Impact of drug stock-outs on death and retention to care among HIV-infected patients on combination antiretroviral therapy in Abidjan, Côte d’Ivoire . PLoS One 2010; 5:
1. Dorward J, Lessells R, Drain PK, Naidoo K, de Oliveira T, Pillay Y, et al. Dolutegravir for first-line antiretroviral therapy in low-income and middle-income countries: uncertainties and opportunities for implementation and research . Lancet HIV 2018; 5:e400–e404.